These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
111 related articles for article (PubMed ID: 7779468)
1. General practitioners' tacit and stated policies in the prescription of lipid lowering agents. Evans JS; Harries C; Dennis I; Dean J Br J Gen Pract; 1995 Jan; 45(390):15-8. PubMed ID: 7779468 [TBL] [Abstract][Full Text] [Related]
2. Coronary risk estimates and decisions on lipid-lowering treatment in primary prevention: comparison between general practitioners, internists, and cardiologists. Vancheri F; Strender LE; Montgomery H; Skånér Y; Backlund LG Eur J Intern Med; 2009 Oct; 20(6):601-6. PubMed ID: 19782921 [TBL] [Abstract][Full Text] [Related]
3. Changes in drug prescribing under the Public Health Reform Law--a survey of general practitioners' attitudes in East and West Germany. Himmel W; Kron M; Thies-Zajonc S; Kochen MM Int J Clin Pharmacol Ther; 1997 Apr; 35(4):164-9. PubMed ID: 9112138 [TBL] [Abstract][Full Text] [Related]
4. Attitudes and practice of New Zealand doctors in the management of patients with dyslipidaemia. Bradley A; Elliott J; White H N Z Med J; 1993 Jun; 106(958):243-7. PubMed ID: 8332291 [TBL] [Abstract][Full Text] [Related]
5. A qualitative study of barriers to the use of statins and the implementation of coronary heart disease prevention in primary care. Kedward J; Dakin L Br J Gen Pract; 2003 Sep; 53(494):684-9. PubMed ID: 15103875 [TBL] [Abstract][Full Text] [Related]
6. Primary prevention of cardiovascular diseases by lipid-lowering treatment in German general practice: results from GPs ignoring guidelines and risk calculators. Oriol-Zerbe C; Abholz HH Eur J Gen Pract; 2007; 13(1):27-34. PubMed ID: 17366291 [TBL] [Abstract][Full Text] [Related]
7. Influences on prescribing in non-fundholding general practices. Eccles MP; Soutter J; Bateman DN; Campbell M; Smith JM Br J Gen Pract; 1996 May; 46(406):287-90. PubMed ID: 8762744 [TBL] [Abstract][Full Text] [Related]
8. Influence exerted on drug prescribing by patients' attitudes and expectations and by doctors' perception of such expectations: a cohort and nested case-control study. Lado E; Vacariza M; Fernández-González C; Gestal-Otero JJ; Figueiras A J Eval Clin Pract; 2008 Jun; 14(3):453-9. PubMed ID: 18373568 [TBL] [Abstract][Full Text] [Related]
9. General Practitioners' coronary risk estimates, decisions to start lipid-lowering treatment, gender and length of clinical experience: their interactions in primary prevention. Vancheri F; Strender LE; Backlund LG Prim Health Care Res Dev; 2013 Oct; 14(4):394-402. PubMed ID: 23351666 [TBL] [Abstract][Full Text] [Related]
10. Proton pump inhibitors: perspectives of patients and their GPs. Grime J; Pollock K; Blenkinsopp A Br J Gen Pract; 2001 Sep; 51(470):703-11. PubMed ID: 11593830 [TBL] [Abstract][Full Text] [Related]
11. Factors associated with discharge lipid-lowering drug prescription in patients hospitalized for coronary artery disease (from the Get With the Guidelines database). Albert NM; Birtcher KK; Cannon CP; Goff DC; Mulgund J; Liang L; Fonarow GC Am J Cardiol; 2008 May; 101(9):1242-6. PubMed ID: 18435951 [TBL] [Abstract][Full Text] [Related]
12. Diurnal variation of prescribing pattern of primary care doctors in Bahrain. Damanhori AH; Al Khaja KA; Sequeira RP; Al-Ansari TM J Eval Clin Pract; 2007 Feb; 13(1):25-30. PubMed ID: 17286720 [TBL] [Abstract][Full Text] [Related]
13. Treatment gap in the use of lipid-lowering drug therapy in diabetes: a population-based study. James P; Tan HH; MacAlpine R; Brennan G; Emslie-Smith A; Morris AD Diabet Med; 2004 Oct; 21(10):1108-12. PubMed ID: 15384958 [TBL] [Abstract][Full Text] [Related]
14. [Factors influencing the prescribing of nootropic drugs. Results of a representative inquiry in Lower Saxony]. Stoppe G; Sandholzer H; Staedt J; Kiefer J; Winter S; Kochen MM; Rüther E Dtsch Med Wochenschr; 1995 Nov; 120(47):1614-9. PubMed ID: 7493562 [TBL] [Abstract][Full Text] [Related]
15. Patients with urinary tract infection: proposed management strategies of general practitioners, microbiologists and urologists. Olesen F; Oestergaard I Br J Gen Pract; 1995 Nov; 45(400):611-3. PubMed ID: 8554842 [TBL] [Abstract][Full Text] [Related]
16. Dyslipidemias and the primary prevention of cardiovascular disease: analysis of the FAMUS primary care register. Xhignesse M; Laplante P; Niyonsenga T; Courteau J; Grant AM Can J Cardiol; 2000 Jul; 16(7):879-85. PubMed ID: 10934306 [TBL] [Abstract][Full Text] [Related]
17. Factors affecting feasibility and acceptability of a practice-based educational intervention to support evidence-based prescribing: a qualitative study. Watkins C; Timm A; Gooberman-Hill R; Harvey I; Haines A; Donovan J Fam Pract; 2004 Dec; 21(6):661-9. PubMed ID: 15528289 [TBL] [Abstract][Full Text] [Related]
18. Prescribing and referral in general practice: a study of patients' expectations and doctors' actions. Webb S; Lloyd M Br J Gen Pract; 1994 Apr; 44(381):165-9. PubMed ID: 8185990 [TBL] [Abstract][Full Text] [Related]
19. Do rural consumers expect a prescription from their GP visit? Investigation of patients' expectations for a prescription and doctors' prescribing decisions in rural Australia. Cutts C; Tett SE Aust J Rural Health; 2005 Feb; 13(1):43-50. PubMed ID: 15720314 [TBL] [Abstract][Full Text] [Related]
20. Policy versus practice: comparison of prescribing therapy and durable medical equipment in medical and educational settings. Sneed RC; May WL; Stencel C Pediatrics; 2004 Nov; 114(5):e612-25. PubMed ID: 15520092 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]